Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS6143022 A
Publication typeGrant
Application numberUS 09/139,285
Publication dateNov 7, 2000
Filing dateAug 24, 1998
Priority dateAug 24, 1998
Fee statusLapsed
Publication number09139285, 139285, US 6143022 A, US 6143022A, US-A-6143022, US6143022 A, US6143022A
InventorsSamuel L. Shull, John E. Nolting
Original AssigneeMedtronic Ave, Inc.
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Stent-graft assembly with dual configuration graft component and method of manufacture
US 6143022 A
Abstract
A stent-graft assembly and method of preparing the same are disclosed. In a first embodiment, the assembly comprises a stent and a graft, wherein the graft has a delivery configuration and a treatment configuration in relation to the stent. In the delivery configuration, the graft material is longer than the stent, covers the outer diameter of the stent, and is folded under and into the inner diameter of the stent. In the treatment configuration, the graft is shorter in length than the stent, such that the graft is no longer folded under the ends and the end regions of the stent are uncovered. The graft is sufficiently affixed to the stent to prevent migration of the graft, yet sufficiently free of the stent such that it can assume a second configuration upon deployment of the device.
Images(6)
Previous page
Next page
Claims(2)
What is claimed is:
1. A stent-graft assembly comprising:
a generally cylindrical, radially expandable stent having a length and first and second ends;
a generally tubular, radially expandable graft member having first and second ends, a first length when in a first configuration and a second length when in a second configuration, said first length being greater than said second length and, said graft member covering said stent;
wherein said first length of said graft member is greater than the length of said stent when said graft member is in said first configuration;
wherein the ends of the graft member are folded over the ends of the stent when the graft member is in said first configuration, and the ends of said graft member are not folded over the ends of the stent when the graft member is in said second configuration; and
wherein said graft member is in said first configuration prior to expansion of the stent, and said second configuration following expansion of said stent.
2. The stent-graft assembly of claim 1 wherein the length of the graft member when in the second configuration is between 20% and 40% less than the length of the graft when the graft is in the first configuration.
Description
FIELD OF THE INVENTION

The present invention relates generally to endoluminal prostheses used in the treatment of stenotic or diseased lumens, and methods of making such prostheses. More particularly, the invention relates to a covered endoluminal prosthesis assembly and methods of making the assembly.

BACKGROUND OF THE INVENTION

Numerous expandable endoluminal prostheses are known in the art which are adapted for temporary or permanent implantation within a body lumen for maintaining the patency of the lumen. Examples of lumens, both native and artificially made, in which endoluminal prostheses may be implanted include, without limitation: arteries, such as those located within the coronary, mesentery, peripheral, or cerebral vasculature; veins; gastrointestinal tract; biliary tract; urethra; trachea; hepatic shunts; and fallopian tubes.

Each of the various types of endoluminal prostheses known in the art provides a uniquely beneficial structure to modify the mechanics of the targeted luminal wall. Many devices known in the art are also designed to provide a desirable healing surface for the vessel wall following treatment. Others are designed to achieve further objectives such as, for example, excluding an aneurysm.

For example, devices generally referred to as stents provide radial support to the lumen. Stents may be mechanically expandable, balloon expandable or self-expanding. Stent-grafts are typically stents with a covering, lining, coating, or some combination of the foregoing. Various grafts, stents, and combination stent-graft prostheses have been previously disclosed for implantation within body lumens.

A common procedure to enlarge a stenotic or diseased blood vessel is known as percutaneous transluminal angioplasty, or PTA. PTA employs an angioplasty balloon catheter which is inserted at a site remote from the site of treatment, tracked to the stenosis, and placed across the lesion. The balloon is then inflated to dilate the artery. In order to prolong the positive effects of PTA and to provide long-term radial support to the treated vessel, a stent or stent-graft may be implanted in conjunction with the procedure. Under this procedure, the stent may be mounted on the balloon, collapsed to an insertion diameter, delivered to the treatment site within the affected lumen, and deployed to its desired diameter for treatment. Because the procedure requires insertion of the stent at a site remote from the site of treatment, the device must be guided through the potentially tortuous conduit of the body lumen to the treatment site. Therefore, the stent must be capable of being reduced to a small insertion diameter and must be flexible.

During an angioplasty procedure, atheromatous plaques within the vessel can undergo fissuring, thereby creating a thrombogenic environment in the lumen. Excessive scarring may also occur following the procedure, potentially resulting in restentosis or reocclusion of the treated lumen. Attempts to address these problems include providing a suitable surface within the lumen for more controlled healing to occur in addition to the support provided by a stent. These attempts include providing a lining or covering in conjunction with an implanted stent. A stent with such a lining or covering is known in the art as a stent-graft.

Specific examples of stents include U.S. Pat. Nos. 5,292,331 and 5,674,278, both issued to Boneau, which are herein incorporated by reference. The stent of Boneau comprises a, or a series of sinusoidally shaped ring-like. Such a stent exhibits excellent radial strength and flexibility.

Other types of stents are disclosed in U.S. Pat. Nos. 4,733,665, 4,776,337, 4,739,762 and 5,102,417 all issued to Palmaz, U.S. Pat. No. 5,195,984 issued to Schatz, U.S. Pat. No. 5,421,955 issued to Lau et al., or U.S. Pat. No. 5,449,373 issued to Pinchasik et al. Such stents include examples of stents created by removing material, such as by cutting or forming, from a thin-walled tube or sheet of material.

All of the foregoing examples of stents may be used alone or in conjunction with a graft. The graft component, or membrane, of a stent-graft may prevent excessive tissue prolapse or protrusion of tissue growth through the interstices of the stent while allowing limited tissue in-growth to occur to enhance the implantation. The surface of the graft material at the same time may minimize thrombosis, prevent scarring from occluding the lumen, prevent embolic events and minimize the contact between the fissured plaque and the hematological elements in the bloodstream.

A combination stent-graft may serve other objectives, such as delivering therapeutic agents via the assembly, excluding aneurysms or other malformations, occluding a side branch of a lumen without sacrificing perforator branches, conferring radiopacity on the device, and others. Various designs to achieve these objectives include stents partially or completely coated or covered with materials, some of which are impregnated with therapeutic agents, radiopaque elements, or other features designed to achieve the particular objectives of the device.

Various methods of manufacturing graft devices alone have been disclosed in the art. One such method for manufacturing a graft is disclosed in U.S. Pat. No. 5,641,373, issued to Shannon et al. The disclosed method comprises reinforcing an extruded fluoropolymer tube with a second fluoropolymer tube. The second tube is prepared by winding fluoropolymer tape around the exterior of a mandrel and heating it to form a tube. The graft may then be mounted on an anchoring mechanism such as a stent or other fixation device.

Another example of a graft is disclosed in U.S. Pat. No. 4,731,073, issued to Robinson. The graft disclosed therein comprises multiple layers of segmented polyether-polyurethane which form multiple zones having varying porosities.

U.S. Pat. No. 5,628,786, issued to Banas, discloses a polytetrafluoroethylene (PTFE) graft which has a reinforcing structure integrally bound to the graft. The reinforcing structure may be in the form of a rib which is sintered or otherwise integrally bound to the graft.

U.S. Pat. No. 5,207,960, issued to Moret de Rocheprise, discloses a process for the manufacture of a thin-walled tube of fluorinated resin tape. The method includes winding the tape around a mandrel and sintering the tape. While still on the mandrel, the tube is rolled to elongate the tube, to reduce the thickness of the tube, and to facilitate removal of the tube from the mandrel. The patent discloses that the tubes obtained can be used particularly as sheaths for the lining of metal tubes.

There are also numerous examples of combination stent-grafts disclosed in the art. U.S. Pat. No. 5,667,523 issued to Bynon et al. discloses a stent-graft comprising two stents and graft material positioned between the two stents.

U.S. Pat. No. 5,653,747 issued to Dereume discloses a stent to which a graft is attached. The graft component is produced by extruding polymer in solution into fibers from a spinnerette onto a rotating mandrel. A stent may be placed over the fibers while on the mandrel and then an additional layer of fibers spun onto the stent. The layer or layers of fibers may be bonded to the stent and/or one another by heat or by adhesives.

PCT Application WO 95/05132 discloses a stent around which a thin film of PTFE has been wrapped circumferentially one time and overlapped upon itself to form a seam. The stent may be alternatively or additionally placed to cover the interior of the stent. Fluorinated ethylene propylene is used as an adhesive to affix the graft to the stent.

An example of a stent and tubular graft is disclosed in U.S. Pat. No. 5,522,882 issued to Gaterud, et al. Gaterud discloses an expandable stent mounted on a balloon and a graft mounted over the stent.

U.S. Pat. No. 5,123,917 issued to Lee discusses a flexible and expandable inner tube upon which separate ring-like scaffold members are mounted, and a flexible and expandable outer tube enclosing the inner tube and scaffold members. The rings may be secured to the inner liner with an adhesive layer. Alternatively, the liners may be adhered to each other with the rings trapped between the layers. Lee discloses that the luminal surface of the device may be coated with various pharmacological agents.

Similarly, U.S. Pat. Nos. 5,282,823 and 5,443,496, both issued to Schwartz, et al. disclose a stent with a polymeric film extending between the stent elements, and strain relief means in the form of cuts in the film to allow the stent to fully expand and conform to the interior of the lumen. The thin polymeric film is applied to the stent while in solution and dried. Once dried, cuts are made in the film to provide strain relief means.

Another assembly includes a stent embedded in a plastic sleeve or stitched or glued to a nylon sleeve, as in U.S. Pat. No. 5,507,771, issued to Gianturco. Other references disclosing devices in which the graft is stitched to the stent include European Patent Application EP 0 686 379 A2, which teaches a perforate tubular frame having a fabric liner stitched to the frame, and World Intellectual Property Organization Application Number WO 96/21404 which indicates that the graft be stitched to the stent, and possibly to loops or eyelets which are part of the stent structure.

U.S. Pat. No. 5,637,113 issued to Tartaglia teaches a stent with a sheet of polymeric film wrapped around the exterior. Tartaglia teaches that the film is attached to the stent at one end by an adhesive, by a hook and notch arrangement, or by dry heat sealing. The polymer can also be attached to the stent by wrapping the film circumferentially around the stent and attaching the polymer film to itself to form a sleeve around the stent by heating and melting the film to itself, adhesive bonding, solvent bonding, or by mechanical fastening, such as by a clip. The film may be loaded or coated with a therapeutic agent.

U.S. Pat. No. 5,628,788, issued to Pinchuk, discloses a process of melt-attaching a graft to a stent by disposing a layer of material between the stent and graft which has a lower melting point than the graft, and heating the assembly to the melting point of the low-melting point material. Pinchuk also teaches adhering a textile graft to a stent by coating a stent with vulcanizing silicone rubber adhesive and curing the adhesive. Pinchuk discloses a similar stent-graft assembly in European Patent Application EP 0 689 805 A2 and teaches that the graft member can be bonded to the stent member thermally or by the use of adhesive agents.

Similarly, World Intellectual Property Organization Application No. WO 95/05132 discloses a stent with an inner and/or an outer liner wrapped around the stent to form a seam, with the liner(s) affixed using an adhesive or melt-attached using a layer of a material with a lower melting point.

U.S. Pat. No. 5,645,559, issued to Hachtman, et al., discloses a multiple layer stent-graft assembly comprising a first layer defining a hollow tubular construction, a second layer having a self-expanding braided mesh construction and a layer of polymeric material disposed between the first and second layers. The polymeric material may be adhered by two-sided adhesive tape. The self-expanding braided mesh, the tubular material, or both may be larger in diameter in the distal regions than in the medial region.

U.S. Pat. No. 5,534,287, issued to Lukic, discloses methods which result in a covered stent, the covering adhered via a lifting medium.

U.S. Pat. No. 5,674,241, issued to Bley, et al. teaches that a hydrophilic polymer layer may be laminated, embedded, coated, extruded, incorporated, or molded around an expandable mesh stent while the stent is in its collapsed condition, and the stent and graft permitted to expand upon hydration.

European Patent Application No. EP 0 775 472 A2 discloses a PTFE-covered stent. The stent can be covered by diagonally winding an expanded PTFE tape under tension around an at least partially expanded stent.

Challenges arising in the art which none of the prior art adequately addresses include achieving an optimal stent-graft design for delivery and deployment of the device. Other challenges which are not adequately addressed by the prior art include minimizing, if not eliminating, migration of the stent, graft or stent-graft; and minimizing thrombogenic potential, vessel reocclusion and tissue prolapse following deployment. Shortcomings associated with the prior art include: assemblies with undesirably large crossing profiles; assemblies with insufficient flexibility; inadequate adhering of coatings and coverings to stents; failure to shield the injured vascular surface; failure to prevent tissue ingrowth from occluding the lumen; failure to minimize the embolization of particles loosely adherent to the vessel wall (especially during device placement and deployment); and increased thrombogenic potential arising from flaps formed in the graft material.

SUMMARY OF THE INVENTION

The present invention and its varied embodiments address several problems associated with the prior art. It is a first objective of this invention to provide an improved stent-graft assembly for the repair and support of a body lumen. It is a second objective of this invention to provide an improved stent-graft assembly with ample radial strength and minimal thrombogenic potential without appreciably increasing the profile of the device over that of the stent alone.

It is a further objective of this invention to provide a stent-graft assembly in which the graft component is both sufficiently secured to the stent, yet sufficiently free during deployment of the device to achieve a desired configuration of the graft component with respect to the stent. Further, the stent and graft have a delivery configuration and an alternative, post-deployment configuration.

An additional objective of this invention is to balance the need for some tissue in-growth against the need to minimize thrombogenic potential and excessive cell growth through the interstices of the stent. This objective is also achieved by providing a stent-graft assembly which shields the injured vascular surface throughout, controls excessive tissue in-growth through the stent, and minimizes the embolization of particles loosely adherent to the vessel wall especially during placement and deployment of the device. The device can also be used to control the luminal protrusion of dissection planes created during PTA or spontaneous fissuring.

A stent-graft assembly according to the present invention first comprises a generally cylindrical stent. Further, the stent-graft includes a graft member or covering disposed about its outer diameter which comprises a first length before deployment and a second length after deployment. Further, the graft comprises a delivery configuration and a treatment configuration. Before deployment, the graft member has a greater length than the stent, and the ends of the graft are inverted to line the inner diameter of the stent, generally at the ends of the stent. The graft member is radially distensible. Upon expansion of the device, the graft component foreshortens such that it unfolds, pulls away from the inner diameter of the stent, and does not cover the ends of the stent once deployment is complete. A suture or sutures attaching the graft to the stent ensures that the graft remains well-centered over the stent during deployment.

The method of manufacturing the assembly according to a first embodiment of the present invention comprises helically wrapping a polymeric tape around a mandrel. The tape is wrapped at a particular angle to the perpendicular axis of the mandrel in order to achieve the desired distensibility of the membrane. The method further comprises sintering the tape to itself over the mandrel under particular parameters to produce a thin tube with desired radial distensibility; removing the thin tube from the mandrel; covering the stent with the thin tube; suturing the graft to the stent; and invertedly folding the ends of the graft over the ends of the stent.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 illustrates a perspective view of a suitable stent for use in the present invention.

FIG. 2 illustrates a perspective view of an embodiment of the stent-graft assembly according to the present invention prior to deployment.

FIG. 3 illustrates a perspective view of an embodiment of the stent-graft assembly according to the present invention following deployment.

FIGS. 4-7 illustrate a stent-graft assembly as it appears following illustrative, successive steps of preparation of the assembly.

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

The thin-walled stent-graft assembly according to the present invention is shown in FIG. 2. One recommended stent for use as the stent member according to the present invention is shown as stent 5 in FIG. 1. Other stents, including but not limited to those disclosed in U.S. Pat. No. 4,733,417 issued to Palmaz, U.S. Pat. No. 5,195,984 issued to Schatz, or U.S. Pat. No. 5,514,154 issued to Lau may also be suitable for use in the stent graft assembly.

Stent 5 is shown in FIG. 1 to include a series of connected, individual sinusoidal-shaped stent elements 10. Stent 5 can comprise any number of stent elements 10, including simply one such element. Each individual element is similar in design and construction to the endovascular support device disclosed in U.S. Pat. No. 5,292,331 issued to Boneau, the disclosure of which is incorporated herein. For the purpose of further illustration, however, the series of adjacent rings or circumferential wires form support members, such as is shown for the purpose of illustration at support member 11. Each ring is formed to include a sinusoidal or serpentine shape which includes a plurality of peaks and substantially straight support members or struts extending longitudinally between adjacent peaks. An example is such as is shown at strut 12 which extends between peaks 13 and 14. Each ring is further connected to an adjacent ring in at least one location where the peaks of their serpentine shape meet, resulting in an interconnected series of stent elements which forms the generally cylindrical stent 5. Stent 5 further forms a prosthesis passageway 16 extending through the plurality of adjacent, serpentine-shaped rings along longitudinal axis L, and between proximal prosthesis port 17 and distal prosthesis port 18.

Further to the interconnected series of stent elements and their respective wire-like support members which form cylindrical body 15 as shown in FIG. 1, spaces remain along cylindrical body 15 between adjacent peaks of each shaped ring and also between adjacent rings, particularly where the individual peaks of adjacent rings extend away from each other relative to longitudinal axis L.

Turning now to FIG. 2, a stent-graft assembly according to one embodiment of the present invention comprises a stent 9 comprising a plurality of stent elements such as stent element 110 comprising a plurality of peaks such as indicated at 113, 114, 115 and 116. In the embodiment depicted in FIG. 2, peaks of successive stent elements such as stent elements 110 and 210 meet one another. For example, peak 113 of stent element 110 is proximate peak 114 of stent element 210. Further, one or more, but preferably each peak of the stent elements at the ends of the device adjoin the contiguous peak of the adjacent stent element. For example, peak 113 adjoins peak 114. Consequently, the rings or stent elements on each end of the device of FIG. 2 are connected to the remainder of the stent at each peak, such as by fusing, welding, soldering or other suitable method. If a stent which is cut from a tube is utilized in preparing the assembly, such connections are left intact. Such connections prevent graft 20 or other similar graft from lapsing between the peaks during and after deployment of the device, and increase the radial strength of the device.

The assembly of FIG. 2 further comprises graft 20 which in this embodiment covers the stent to define a relatively continuous vascular surface 22, but which in alternate embodiments may line the inner diameter of the stent to form a luminal surface, or may define both a vascular and luminal surface. The graft is preferably between 0.001 and 0.003 inch in thickness, is radially distensible, and foreshortens over a range of between 20 and 50 per cent from its primary or initial length. Suitable material for the graft may be synthetic and is preferably expanded polytetrafluoroethylene (ePTFE), but may include and is not limited to polyesters, polyurethane and silicone.

Graft 20 is folded invertedly to define a luminal surface 21 adjacent the proximal prosthesis port 117 and adjacent the distal prosthesis port 118. Suture 25 ensures that the graft remains well-centered over the stent during deployment of the device.

FIG. 3 illustrates the stent graft assembly of FIG. 2 following deployment. Graft 20 is no longer folded to define a luminal surface, but rather has foreshortened to unfold and to come away from the inner diameter of the stent. Peaks (such as peak 116) which define proximal prosthesis port 117 and distal prosthesis port 118 may now be exposed. Preferably, the graft remains over essentially the entire length of the stent, but may recede as far as to expose the entire stent elements at the ends of the stent.

A portion of the method of preparation of the thin-walled graft component is illustrated in FIGS. 4 and 5. Successive helical windings 70 of the polymeric tape 72 overlap to a relatively large extent given the steep angle of orientation of the tape to the axis perpendicular to the mandrel. The finished graft component is greatly distensible as a result of the angle α of the tape to the axis P, which is perpendicular to the longitudinal axis of the mandrel. In general, the greater the angle α, the greater the radial distensibility. The degree of distensibility is also somewhat affected by the sintering process, but to a lesser degree than as a result of the wrap angle. In this embodiment angle α may be between 70 and 87 degrees, and is preferably between 80 and 85 degrees. The tape is wound beginning from one end of the mandrel progressively to the other end of the mandrel. The ends of the wrapped tape tube may be clamped to the mandrel in order to prevent foreshortening of the tube during the sintering process, which follows.

The wrapped mandrel is then subject to a sufficient temperature for a sufficient time to sinter the overlapping layers together. For example, a ePTFE-wrapped mandrel is subject to a temperature between 360 and 370 degrees C for between 20 and 60 minutes to sinter the overlapping portions together. Pressure may be utilized in conjunction with sintering to improve the adherence of the tape windings to one another. The ends 74 of the tube may then be trimmed to form a tube of desired length.

Graft 40 is then removed from the mandrel. If, because the tube constricts to some degree during sintering, difficulty is encountered in removing the tube from the mandrel, several methods to facilitate removing the tube may be used. Compressed air may be discharged at one end of the tube between the tube and the mandrel, or a flat tool may be used to loosen any temporary adhesion between the mandrel and the tube. Alternatively, a collapsible mandrel or a bar of reducible diameter may be used. Also, a lubricant such as silicone, can be introduced to facilitate removal of the tube from the mandrel.

Newly prepared graft 40 is then loaded over stent 30, as depicted in FIG. 6. Graft 40 is centered over and sutured to the stent, preferably utilizing a polypropylene suture material. The ends of the suture material and/or the knot formed in suture 35 may then be melted utilizing a point contact device. Ends 74 of graft 40 are then folded invertedly into the proximal prosthesis port 50 and distal prosthesis port 51, to define luminal surface 60 adjacent proximal prosthesis port 50 and a luminal surface (not pictured) adjacent distal prosthesis port 51. The finished stent-graft assembly 80 according to one embodiment of the invention is depicted in FIG. 7. Specific examples of manufacturing the assembly follow.

EXAMPLE 1

For the purpose of further illustration, an exemplary method for preparing a stent-graft assembly is described as follows. A thin tape of ePTFE, manufactured by Baxter, Inc., of approximately 0.0004 inch in thickness, was wound around a 0.047 inch mandrel under slight tension at approximately an 85 degree angle to the perpendicular axis of the mandrel. The wrapped mandrel was sintered at 367 degrees Celsius for 25 minutes. After cooling, the tube was removed from the mandrel and trimmed to form a 20.5 mm long tube.

A GFX stent, which is manufactured by Arterial Vascular Engineering, Inc., in Santa Rosa, Calif., was provided in a 18 mm length. Each peak of the stent elements at the ends of the stent which abutted an adjacent peak were welded to the abutting peak.

The thin ePTFE tube was removed from the mandrel and placed, well-centered, over the stent. The graft was then attached to the stent with two polypropylene sutures. The ends of the suture material and knot formed by the ends were melted using a heated point contact device at 360 degrees F. The graft material, which extends beyond the ends of the stent, was then folded invertedly to touch the inner diameter of the stent at the ends.

EXAMPLE 2

A further example of a method of preparation of a stent-graft assembly according to the invention is as follows. ePTFE tape manufactured by Baxter, Inc. was circumferentially wrapped around a 0.058 inch mandrel, under slight tension at approximately an 85 degree angle to the perpendicular axis of the mandrel. The tape-wrapped mandrel was then sintered at 367 degrees Celsius for 25 minutes. The sintered tape and mandrel were allowed to cool, and the ends of the graft were trimmed, resulting in a 23 mm long graft.

A 21 mm long GFXtra stent manufactured by Arterial Vascular Engineering, Inc. was provided. Additional welds at the end stent elements between abutting peaks were made. The graft was loaded over the stent. The graft, well-centered, was sutured to the stent using polypropylene suture material. The ends of the suture material and knot formed by the ends were melted using a heat point contact device at 360 degrees F. The ends of the graft were then folded under, into the inside of the stent, and against the interior surface of the stent.

A stent-graft assembly having a graft having a dual configuration and method of manufacturing the same have been disclosed. Although the present invention has been described in accordance with the embodiments shown, one of ordinary skill in the art will readily recognize that there could be variations to the embodiments and those variations would be within the spirit and scope of the present invention.

A wide variety of suitable materials used for stents and grafts may be interchanged without diverging from the methods or structures of the invention claimed. For example, the type of stent utilized could be varied greatly. The embodiments disclosed herein focus on a stent comprising independent support members, but an alternate stent which is comprised of a slotted tube or of a rolled film or sheet configuration may also be used. Further, suitable stents include stents made of nitinol or other shape memory alloy. In order to confer or enhance radiopacity on an alternative stent, various methods may be utilized. For example, a radiopaque metal marker such as gold, tantalum, platinum, iridium or any alloy thereof may be attached to the graft material.

Further, the instant invention can also be used for indications other than repairing and/or providing radial support to a body lumen. Other examples include aneurysm isolation and vessel occlusion. The foregoing embodiments and examples are illustrative and are in no way intended to limit the scope of the claims set forth herein.

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US4300244 *Sep 19, 1979Nov 17, 1981Carbomedics, Inc.Cardiovascular grafts
US4728328 *Jun 3, 1985Mar 1, 1988Research CorporationCuffed tubular organic prostheses
US4731073 *May 21, 1984Mar 15, 1988Thoratec Laboratories CorporationArterial graft prosthesis
US4776337 *Jun 26, 1986Oct 11, 1988Expandable Grafts PartnershipExpandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US5078726 *Apr 9, 1990Jan 7, 1992Kreamer Jeffry WGraft stent and method of repairing blood vessels
US5123917 *Apr 27, 1990Jun 23, 1992Lee Peter YExpandable intraluminal vascular graft
US5207960 *May 29, 1991May 4, 1993Compagnie Plastic OmniumSintering, rolling, elongation, extraction
US5282823 *Mar 19, 1992Feb 1, 1994Medtronic, Inc.Intravascular radially expandable stent
US5282860 *Oct 8, 1992Feb 1, 1994Olympus Optical Co., Ltd.Stent tube for medical use
US5330500 *Oct 17, 1991Jul 19, 1994Song Ho YSelf-expanding endovascular stent with silicone coating
US5360443 *Jun 11, 1990Nov 1, 1994Barone Hector DAortic graft for repairing an abdominal aortic aneurysm
US5389106 *Oct 29, 1993Feb 14, 1995Numed, Inc.Impermeable expandable intravascular stent
US5443496 *Oct 15, 1993Aug 22, 1995Medtronic, Inc.Intravascular radially expandable stent
US5449382 *Mar 2, 1994Sep 12, 1995Dayton; Michael P.Minimally invasive bioactivated endoprosthesis for vessel repair
US5489295 *May 21, 1993Feb 6, 1996Endovascular Technologies, Inc.For repairing an aortic aneurysm
US5507771 *Apr 24, 1995Apr 16, 1996Cook IncorporatedStent assembly
US5522880 *Jun 22, 1994Jun 4, 1996Barone; Hector D.Method for repairing an abdominal aortic aneurysm
US5522881 *Jun 28, 1994Jun 4, 1996Meadox Medicals, Inc.Implantable tubular prosthesis having integral cuffs
US5522882 *Oct 21, 1994Jun 4, 1996Impra, Inc.Method and apparatus for balloon expandable stent-graft delivery
US5534287 *Nov 29, 1994Jul 9, 1996Schneider (Europe) A.G.Methods for applying an elastic coating layer on stents
US5556414 *Mar 8, 1995Sep 17, 1996Wayne State UniversityAssembly for insertion into a body passageway
US5562728 *Apr 12, 1995Oct 8, 1996Endovascular Tech IncEndovascular grafting apparatus, system and method and devices for use therewith
US5571173 *Jun 6, 1995Nov 5, 1996Parodi; Juan C.Graft to repair a body passageway
US5578071 *Oct 1, 1993Nov 26, 1996Parodi; Juan C.Aortic graft
US5578072 *Aug 1, 1994Nov 26, 1996Barone; Hector D.Aortic graft and apparatus for repairing an abdominal aortic aneurysm
US5591195 *Oct 30, 1995Jan 7, 1997Taheri; SydeApparatus and method for engrafting a blood vessel
US5628785 *Apr 27, 1995May 13, 1997Medtronic, Inc.Molding and reacting a mixture of fibrin and elastin on a spacings-containing element; radially compressing to deliver to arterial lumens
US5628786 *May 12, 1995May 13, 1997Impra, Inc.Radially expandable vascular graft with resistance to longitudinal compression and method of making same
US5628788 *Nov 7, 1995May 13, 1997Corvita CorporationSelf-expanding endoluminal stent-graft
US5632772 *Nov 13, 1995May 27, 1997Corvita CorporationExpandable supportive branched endoluminal grafts
US5637113 *Dec 13, 1994Jun 10, 1997Advanced Cardiovascular Systems, Inc.Polymer film for wrapping a stent structure
US5639278 *Nov 13, 1995Jun 17, 1997Corvita CorporationExpandable supportive bifurcated endoluminal grafts
US5641373 *Apr 17, 1995Jun 24, 1997Baxter International Inc.Method of manufacturing a radially-enlargeable PTFE tape-reinforced vascular graft
US5645559 *Dec 21, 1993Jul 8, 1997Schneider (Usa) IncMultiple layer stent
US5653743 *Sep 9, 1994Aug 5, 1997Martin; Eric C.Hypogastric artery bifurcation graft and method of implantation
US5653747 *Oct 20, 1995Aug 5, 1997Corvita CorporationLuminal graft endoprostheses and manufacture thereof
US5667523 *Apr 28, 1995Sep 16, 1997Impra, Inc.Dual supported intraluminal graft
US5674241 *Jul 15, 1996Oct 7, 1997Menlo Care, Inc.Expandable stent body, hydration expandable polymer layer
US5674276 *Aug 1, 1994Oct 7, 1997Boston Scientific CorporationTubular medical prosthesis
US5681345 *Dec 30, 1996Oct 28, 1997Scimed Life Systems, Inc.Sleeve carrying stent
US5683448 *Nov 23, 1994Nov 4, 1997Boston Scientific Technology, Inc.Intraluminal stent and graft
US5683453 *Jan 18, 1996Nov 4, 1997Expandable Grafts PartnershipApparatus for bilateral intra-aortic bypass
US5693085 *Apr 26, 1995Dec 2, 1997Scimed Life Systems, Inc.Stent with collagen
US5700285 *Jun 7, 1995Dec 23, 1997W. L. Gore & Associates, Inc.Intraluminal stent graft
US5713917 *Sep 18, 1996Feb 3, 1998Leonhardt; Howard J.Apparatus and method for engrafting a blood vessel
US5723004 *Jan 31, 1996Mar 3, 1998Corvita CorporationExpandable supportive endoluminal grafts
US5735892 *Aug 18, 1993Apr 7, 1998W. L. Gore & Associates, Inc.Intraluminal stent graft
US5741324 *Jan 24, 1996Apr 21, 1998Cordis CorporationMethod for manufacturing a stent and stent obtained with said method
US5749880 *Jul 27, 1995May 12, 1998Impra, Inc.Endoluminal encapsulated stent and methods of manufacture and endoluminal delivery
EP0466518A2 *Jul 15, 1991Jan 15, 1992Endovascular Technologies, Inc.Endovascular grafting apparatus and system
EP0556850A1 *Feb 19, 1993Aug 25, 1993Mintec IncIntraluminal stent
EP0621016A1 *Apr 15, 1994Oct 26, 1994C.R. Bard, Inc.Non-migrating vascular prosthesis and minimally invasive placement system therefor
EP0657147A2 *Oct 25, 1994Jun 14, 1995C.R. Bard, Inc.Non-migrating vascular prosthesis and minimally invasive placement system therefor
EP0686379A2 *Jun 2, 1995Dec 13, 1995Cardiovascular Concepts, Inc.Apparatus for endoluminal graft placement
EP0689805A2 *Jun 12, 1995Jan 3, 1996Corvita CorporationBistable luminal graft endoprostheses
EP0701800A1 *Sep 15, 1995Mar 20, 1996C.R. Bard, Inc.Method and apparatus for recapture of hooked endoprosthesis
EP0712614A1 *Nov 15, 1995May 22, 1996Advanced Cardiovascular Systems, Inc.Intraluminal stent for attaching a graft
EP0747020A2 *Feb 14, 1996Dec 11, 1996Cook IncorporatedImproved barb and expandable transluminal graft prothesis for repair of aneurysm
EP0775472A2 *Nov 20, 1996May 28, 1997Schneider (Usa) Inc.,Expandable stent graft covered with expanded polytetrafluoroethylene
EP0797963A2 *Mar 25, 1997Oct 1, 1997Corvita CorporationStents and stent-grafts
EP0819412A2 *Jul 14, 1997Jan 21, 1998Cordis CorporationLow profile, thermally set wrapped cover for a percutaneously deployed stent
WO1984003036A1 *Jan 26, 1984Aug 16, 1984Wallsten Hans IvarBlood vessel prosthesis
WO1995005132A1 *May 4, 1994Feb 23, 1995Gore & AssAn intraluminal stent graft
WO1996014808A1 *Nov 8, 1995May 23, 1996Advanced Cardiovascular SystemDelivery catheter and graft for aneurysm repair
WO1996021404A1 *Jan 16, 1996Jul 18, 1996Prograft Medical IncKink-resistant stent-graft
WO1996039104A1 *Jun 5, 1996Dec 12, 1996Devices Vascular InterventionProsthetic graft and method for aneurysm repair
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US6344054 *Jun 21, 1999Feb 5, 2002Juan Carlos ParodiEndoluminal prosthesis comprising stent and overlying graft cover, and system and method for deployment thereof
US6565599 *Dec 28, 2000May 20, 2003Advanced Cardiovascular Systems, Inc.Hybrid stent
US6663607 *Jul 12, 1999Dec 16, 2003Scimed Life Systems, Inc.Bioactive aneurysm closure device assembly and kit
US6669647Apr 23, 2002Dec 30, 2003Medtronic Ave, Inc.Sensing device and method for determining aneurysmal pressure in a body cavity
US6770089Dec 26, 2001Aug 3, 2004Advanced Cardiovascular Systems, Inc.Hybrid stent fabrication using metal rings and polymeric links
US6776604Dec 20, 2001Aug 17, 2004Trivascular, Inc.Method and apparatus for shape forming endovascular graft material
US6786919 *Jul 10, 2001Sep 7, 2004Endovascular Technologies, Inc.Self-expanding intravascular device with protector members
US6805705Mar 31, 2003Oct 19, 2004Advanced Cardiovascular Systems, Inc.Hybrid stent
US6929709 *Jan 25, 2002Aug 16, 2005Scimed Life Systems, Inc.Helically formed stent/graft assembly
US7001419 *Oct 2, 2001Feb 21, 2006Boston Scientific Scimed, Inc.Stent delivery system with membrane
US7090693 *Dec 20, 2001Aug 15, 2006Boston Scientific Santa Rosa Corp.Endovascular graft joint and method for manufacture
US7118592Sep 12, 2000Oct 10, 2006Advanced Cardiovascular Systems, Inc.Covered stent assembly for reduced-shortening during stent expansion
US7131991Apr 24, 2002Nov 7, 2006Medtronic Vascular, Inc.Endoluminal prosthetic assembly and extension method
US7147455Jun 14, 2004Dec 12, 2006Boston Scientific Santa Rosa Corp.Method and apparatus for shape forming endovascular graft material
US7179284 *Aug 8, 2003Feb 20, 2007Endotex Interventional Systems, Inc.Stretchable anti-buckling coiled-sheet stent
US7189255 *Oct 28, 2003Mar 13, 2007Cordis CorporationProsthesis support ring assembly
US7285125Oct 5, 2005Oct 23, 2007Tyco Healthcare Group LpCompression anastomosis device and method
US7308515Oct 5, 2005Dec 11, 2007Quanta Computer Inc.Devices and methods for signal switching and processing
US7455687Dec 30, 2002Nov 25, 2008Advanced Cardiovascular Systems, Inc.Polymer link hybrid stent
US7500988 *Nov 16, 2000Mar 10, 2009Cordis CorporationStent for use in a stent graft
US7559947Sep 27, 2006Jul 14, 2009Abbott LaboratoriesEndoprosthesis having foot extensions
US7572286 *May 13, 2002Aug 11, 2009Advanced Cardiovascular Systems, Inc.Stent assembly for the treatment of vulnerable plaque
US7625398Nov 19, 2004Dec 1, 2009Abbott LaboratoriesEndoprosthesis having foot extensions
US7625401 *Sep 16, 2005Dec 1, 2009Abbott LaboratoriesEndoprosthesis having foot extensions
US7641683Feb 14, 2007Jan 5, 2010Boston Scientific Scimed, Inc.Stretchable anti-buckling coiled-sheet stent
US7645409Oct 3, 2008Jan 12, 2010Advanced Cardiovascular Systems, Inc.Coating a mandrel with polymeric layers; forming ring cavities in the layers; embedding metal cylindrical rings into the cavities; coating the cylindrical rings and polymeric layers with a second series of polymeric coatings; longitudinal and flexural flexibility; radially expandable; column strength
US7655036Apr 24, 2002Feb 2, 2010Medtronic Vascular, Inc.Bifurcated endoluminal prosthetic assembly and method
US7691461Apr 1, 2002Apr 6, 2010Advanced Cardiovascular Systems, Inc.enhanced flexibility
US7806922Dec 31, 2004Oct 5, 2010Boston Scientific Scimed, Inc.Sintered ring supported vascular graft
US7828840 *Nov 12, 2008Nov 9, 2010Med Institute, Inc.Prevention of vascular disorders such as aneurysm, aortic dissection, specifically abdominal aortic aneurysm; first and second polymer layers, each with a different AT2 receptor antagonist; controlled release
US7854760May 16, 2005Dec 21, 2010Boston Scientific Scimed, Inc.Medical devices including metallic films
US7901447Dec 29, 2004Mar 8, 2011Boston Scientific Scimed, Inc.Medical devices including a metallic film and at least one filament
US7959999Aug 1, 2007Jun 14, 2011Abbott Cardiovascular Systems, Inc.Hybrid stent and method of making
US7985249Feb 21, 2006Jul 26, 2011Abbott Laboratories CorporationEndoprosthesis having foot extensions
US8048146Jun 30, 2006Nov 1, 2011Abbott LaboratoriesEndoprosthesis having foot extensions
US8109948Jul 13, 2007Feb 7, 2012Tyco Healthcare Group LpCompression anastomosis device and method
US8109991Oct 16, 2009Feb 7, 2012Abbot LaboratoriesEndoprosthesis having foot extensions
US8152841Apr 23, 2010Apr 10, 2012Boston Scientific Scimed, Inc.Medical devices including metallic films
US8348989May 8, 2006Jan 8, 2013Trivascular, Inc.Endovascular graft joint and method for manufacture
US8414635 *May 22, 2008Apr 9, 2013Idev Technologies, Inc.Plain woven stents
US8480727Sep 13, 2012Jul 9, 2013Medtronic Vascular, Inc.Endovascular implant having an integral graft component and method of manufacture
US8591568Dec 29, 2004Nov 26, 2013Boston Scientific Scimed, Inc.Medical devices including metallic films and methods for making same
US8628790Oct 8, 2010Jan 14, 2014Pls Technologies, LlcCoating system and method for drug elution management
US8632580 *Dec 29, 2004Jan 21, 2014Boston Scientific Scimed, Inc.Flexible medical devices including metallic films
US8663541Aug 21, 2007Mar 4, 2014Cordis CorporationMethod of forming a tubular membrane on a structural frame
US20090099643 *May 22, 2008Apr 16, 2009Hideki HyodohWoven intravascular devices and methods for making the same
US20090326640 *Feb 1, 2008Dec 31, 2009Shinichi YoshimuraMedical device for body cavity and method of producing the same
US20100204773 *Dec 8, 2009Aug 12, 2010Elmaleh David RDelivery system for intravascular device with netting
US20110137332 *Dec 21, 2009Jun 9, 2011Concentric Medical, Inc., A Delaware Corporation.Devices and methods for treating vascular malformations
US20120259404 *Dec 5, 2011Oct 11, 2012Microvention, Inc.Stent
US20130297003 *Jan 13, 2012Nov 7, 2013Innovia LlcEndoluminal Drug Applicator and Method of Treating Diseased Vessels of the Body
USRE39335 *May 9, 2002Oct 10, 2006Anson Medical LtdSurgical graft/stent system
EP1356785A1Apr 24, 2003Oct 29, 2003Medtronic Ave, Inc.Bifurcated endoluminal prosthetic assembly
EP1356786A1Apr 24, 2003Oct 29, 2003Medtronic Ave, Inc.Endoluminal prosthetic assembly and extension method
EP2149349A2 *May 6, 2003Feb 3, 2010Cordis CorporationMethod of placing a tubular membrane on a sturctural frame
Classifications
U.S. Classification623/1.13, 623/1.16, 623/1.2, 623/1.18
International ClassificationA61F2/06, A61F2/90
Cooperative ClassificationA61F2/915, A61F2/91, A61F2002/075, A61F2002/91541, A61F2002/91558, A61F2/07
European ClassificationA61F2/915, A61F2/91
Legal Events
DateCodeEventDescription
Dec 30, 2008FPExpired due to failure to pay maintenance fee
Effective date: 20081107
Nov 7, 2008LAPSLapse for failure to pay maintenance fees
May 19, 2008REMIMaintenance fee reminder mailed
Mar 29, 2004FPAYFee payment
Year of fee payment: 4
Apr 10, 2002ASAssignment
Owner name: MEDTRONIC AVE, INC., CALIFORNIA
Free format text: MERGER;ASSIGNOR:ARTERIAL VASCULAR ENGINEERING, INC.;REEL/FRAME:012802/0198
Effective date: 19990128
Owner name: MEDTRONIC AVE, INC. 3576 UNOCAL PLACE SANTA ROSA C
Owner name: MEDTRONIC AVE, INC. 3576 UNOCAL PLACESANTA ROSA, C
Free format text: MERGER;ASSIGNOR:ARTERIAL VASCULAR ENGINEERING, INC. /AR;REEL/FRAME:012802/0198
Oct 1, 1998ASAssignment
Owner name: ROYAL BANK OF CANADA, AS ADMINISTRATIVE AGENT, NEW
Free format text: SECURITY INTEREST;ASSIGNOR:ARTERIAL VASCULAR ENGINEERING, INC.;REEL/FRAME:009501/0179
Effective date: 19980930